Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2006-07-11
2009-06-30
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S616000, C562S435000, C562S450000, C564S155000
Reexamination Certificate
active
07553873
ABSTRACT:
The present invention relates to modulators of metalloproteinase activity.
REFERENCES:
patent: 2440649 (1948-04-01), Avakian et al.
patent: 4769389 (1988-09-01), Makovec et al.
patent: 5563127 (1996-10-01), Amparo et al.
patent: 5597825 (1997-01-01), Himmelsbach et al.
patent: 5602179 (1997-02-01), Makovec et al.
patent: 5618825 (1997-04-01), Baldwin et al.
patent: 5648368 (1997-07-01), Egbertson et al.
patent: 5698538 (1997-12-01), Amparo et al.
patent: 5736559 (1998-04-01), Himmelsbach et al.
patent: 5756810 (1998-05-01), Baldwin et al.
patent: 5852007 (1998-12-01), Chatterjee
patent: 5922763 (1999-07-01), Himmelsbach et al.
patent: 6242422 (2001-06-01), Karanewsky et al.
patent: 6306840 (2001-10-01), Adams et al.
patent: 6376538 (2002-04-01), Adams et al.
patent: 6605608 (2003-08-01), Seko et al.
patent: 6624152 (2003-09-01), Adams et al.
patent: 6630512 (2003-10-01), Adams et al.
patent: 6723711 (2004-04-01), Biediger et al.
patent: 2002/0019416 (2002-02-01), Fukami et al.
patent: 2002/0091089 (2002-07-01), Karanewsky et al.
patent: 2002/0169326 (2002-11-01), Fukami et al.
patent: 2003/0013725 (2003-01-01), Seko et al.
patent: 2003/0018016 (2003-01-01), Adams et al.
patent: 2003/0083267 (2003-05-01), Adams et al.
patent: 2003/0199692 (2003-10-01), Biediger et al.
patent: 2003/0232806 (2003-12-01), Seko et al.
patent: 2004/0009956 (2004-01-01), Pei et al.
patent: 2004/0063959 (2004-04-01), Fukami et al.
patent: 2004/0259804 (2004-12-01), Karanewsky
patent: 2005/0049242 (2005-03-01), Robinson et al.
patent: 3332633 (1985-04-01), None
patent: 496378 (1992-07-01), None
patent: 751765 (1997-01-01), None
patent: 805796 (1997-11-01), None
patent: 854863 (1998-07-01), None
patent: 997147 (2000-05-01), None
patent: 1090912 (2001-04-01), None
patent: 1142867 (2001-10-01), None
patent: 1189881 (2002-03-01), None
patent: 1213288 (2002-06-01), None
patent: 1 108 819 (1968-04-01), None
patent: 2292149 (1996-02-01), None
patent: 06192199 (1994-07-01), None
patent: 11080191 (1999-03-01), None
patent: 11116541 (1999-04-01), None
patent: 2002145849 (2002-05-01), None
patent: WO-94/12181 (1994-06-01), None
patent: WO-95/24186 (1995-09-01), None
patent: WO-96/20689 (1996-07-01), None
patent: WO-96/22966 (1996-08-01), None
patent: WO-97/03951 (1997-02-01), None
patent: WO-97/21690 (1997-06-01), None
patent: WO-99/02146 (1999-01-01), None
patent: WO-99/48371 (1999-09-01), None
patent: WO-00/00470 (2000-01-01), None
patent: WO-00/23421 (2000-04-01), None
patent: WO-00/27808 (2000-05-01), None
patent: WO-00/68188 (2000-11-01), None
patent: WO-01/83445 (2001-11-01), None
patent: WO-01/90077 (2001-11-01), None
patent: WO-03/093498 (2003-11-01), None
patent: WO-03093498 (2003-11-01), None
patent: WO-2005/019167 (2005-03-01), None
patent: WO-2005/040355 (2005-05-01), None
patent: WO-2005/058808 (2005-06-01), None
patent: WO-2005/060456 (2005-07-01), None
Baker et al., Journal of Pharmaceutical Science, 1966, 55(3), pp. 295-30, Abstract from STN search report.
Beyermann, et al., “Rapid Continuous Peptide Synthesis via FMOC Amino Acid Chloride Coupling and 4-(aminomethyl)piperidine Deblocking”, Journal of Organic Chemistry, 55(2):721-728 (1990).
Habermehl, et al., “Synthesis of N-[(3-ethoxycarbonylmethyl)-cyclohexyl]-azetidin-2-yl-propionic Acid Hydrochloride”, Zeitschrift Fuer Naturforschung, B: Chemical Sciences, 47(2):1779-1784 (1992).
Jobron, et al. “Solid-Phase Synthesis of New S-Glycoamino Acid Building Blocks”, Organic Letters, 2(15):2265-2267 (2000).
Moroder, et al., “Cytochrome C. Part I.: Synthesis of the Protected Hexadecapeptide (Sequence 1-16) of Baker's Yeast Iso-1-Cytochrome C”, Biopolymers, 12(3):477-492 (1973).
Okada, et al., “Amino Acids and Peptides LVI: Synthesis of Pyrazinone Ring-Containing Opioid Mimetics and Examination of Their Opioid Receptor Binding Activity”, Tetrahedron, 55(50):14391-14406 (1999).
Suresh Babu, et al., “(Fluoren-9-ylmethoxy)carbonyl (Fmoc) Amino Acid Azides: Synthesis, Isolation, Characterisation, Stability and Application to Synthesis of Peptides”, J. Chem. Soc., Perkin Trust, 1:4328-4331 (2000).
Takahashi, et al., “Novel Matrix Metalloproteinase Inhibitors: Generation of Lead Compounds by the in Silico Fragment-Based Approach”, Bioorganic & Medicinal Chemistry, 13(14):4527-4543 (2005).
Wen, et al., “Synthesis of 9-Fluorenylmethoxycarbonyl-Protected Amino Aldehydes”, Tetrahedron: Asymmetry, 9(11):1855-1858 (1998).
Kerwin, et al., “Hybrid Cholecystokinin (CCK) Antagonists: New Implications in the Design and Modification of CCK Antagonists”, J. Med. Chem., 32:739-742 (1989).
Kuefner, et al., “Carboxypeptidase-Mediated Release of Methotrexate from Methotrexate α-Peptides”, Biochemistry, 28:2288-2297 (1989).
International Search Report, Issued Apr. 27, 2007, in PCT/US2006/027066.
Abbaszade, I. et al., “Cloning anc Characterization ofADAMTS11, an Aggrecanase from the ADAMTS Family”,J Biol Chem, 274(33):23443-23450 (1999).
Colige, A. et al., “cDNA Cloning and Expression of Bovine Procollagen I N-Proteinase: A New Member of the Superfamily of Zinc-Metalloproteinases with Binding Sites for Cells and Other Matrix Components”,Proc Natl Acad Sci USA, 94:2374-2379 (1997).
Kuno, et al., “Molecular Cloning of a Gene Encoding a New Type of Metalloproteinase-disintegrin Family Protein with Thrombospondin Motifs as an Inflammation Associated Gene”,Journal of Biological Chemistry, 272(1):556-562 (1997).
Tang, BL, “ADAMTS: a Novel Family of Extracellular Matrix Proteases”,Int J. Biochem Cell Biol, 33:33-44 (2001).
Vazquez, F. et al., “METH-1, a Human Ortholog of ADAMTS-1 and METH-2 are Members of a New Family of Proteins with Angio-inhibitory Activity”,J Biol Chem, 274(33):23349-23357 (1999).
Augeri, et al., “Potent and Selective Non-Cysteine-Containing Inhibitors of Protein Farnesyltransferase”, Journal of Medicinal Chemistry, 41(22):4288-4300 (1998).
Boger, et al., “Conformationally Restricted Analogues Designed for Selective Inhibition of GAR Tfase Versus Thymidylate Synthase or Dihydrofolate Reductase”, Bioorg. Med. Chem., 8:1075-1086 (2000).
Database Beilstein, XP002413080, Database Accession No. BRN 3152508.
Database Beilstein, XP002413081, Database Accession No. BRN 3149561.
Database Beilstein, XP002413082, Database Accession No. BRN 2790059.
Database Beilstein, XP002413083, Database Accession No. BRN 9663820.
Database Beilstein, XP002413084, Database Accession No. BRN 3210937.
Database Beilstein, XP002413085, Database Accession No. BRN 2600925.
Database Beilstein, XP002413086, Database Accession No. BRN 55943.
Database Beilstein, XP002413087, Database Accession No. BRN 2894932.
Database Caplus [Online], XP002413088, “Inhibitory Effect of Methotrexate on Matrix Metalloproteinase-1 (Collagenase) Production by Synovial Fibroblasts”, Database Accession No. 1997:137341.
Makovec, et al., “Structure-Antigastrin Activity Relationships of New (R)-4-Benzamido-5-oxopentanoic Acid Derivatives”, Journal of Medicinal Chemistry, 35(1):28-38 (1992).
Martinelli, et al., “Methotrexate Analogues. 12: Synthesis and Biological Properties of Some Aza Homologues”, Journal of Medicinal Chemistry, 22(7):869-874 (1979).
Piper, et al., “Syntheses of α- and γ-Substituted Amides, Peptides, and Esters of Methotrexate and Their Evaluation as Inhibitors of Folate Metabolism”, Journal of Medicinal Chemistry, 25(2):182-187 (1982).
Springer, et al., “Optimization of Alkylating Agent Prodrugs Derived from Phenol and Aniline Mustards: A New Clinical Candidate Prodrug (ZD2767) for Antibody-Directed Enzyme Prodrug Therapy (ADEPT)”, Journal of Medicinal Chemistry, 38(26):5051-5065 (1995).
PCT Invitation to Pay Additional Fees with Partial International Search Report from PCT Application No. PCT/US2006/027066.
F. Makovec et al. “New glutamic and aspartic derivatives with pote
Feyfant Eric
How David Brian
Mansour Tarek Suhayl
Sabatini Joshua James
Skotnicki Jerauld Stanley
Chu Yong
Dorigo Andrea
Saeed Kamal A
Wyeth
LandOfFree
Glutamate aggrecanase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glutamate aggrecanase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glutamate aggrecanase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4072881